MedTrace Logo

Chemotherapy in Treating Patients With Liver Cancer

NCT00003044 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2013-12-19

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of cisplatin and epinephrine administered directly into the tumor in treating patients who have primary liver cancer that cannot be removed during surgery.

Conditions

Interventions

DRUG

cisplatin-e therapeutic implant

Sponsors & Collaborators

  • Matrix Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Richard D. Leavitt, MD · Matrix Pharmaceutical

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-09-30

Countries

  • United States
  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003044 on ClinicalTrials.gov